Posts
[vc_row][vc_column][vc_custom_heading text=”Posts Shortcodes” use_theme_fonts=”yes” el_class=”shorter”][vc_column_text]You can show the posts with Porto Blog, Porto Recent Posts shortcodes.[/vc_column_text][vc_separator color=”custom” gap=”tall” gradient=”yes”][/vc_column][/vc_row][vc_row][vc_column]
Recent
Cryopreservation in Cell Therapy Workflows: Overcoming the Limitations of DMSO-Based Formulations
Cryopreservation is a crucial step in cell therapy workflows, ensuring the long-term viability and availability of therapeutic cells. However, the... read more
Introduction to the Cell Therapy Workflow
Allogeneic Workflow: In the allogeneic approach, immune cells are sourced from healthy donors or established cell banks rather than the patient... read more
Timeline
Grid
Masonry
Cryopreservation in Cell Therapy Workflows: Overcoming the Limitations of DMSO-Based Formulations
Cryopreservation is a crucial step in cell therapy workflows, ensuring the long-term viability and availability of therapeutic cells. However, the use of traditional dimethyl sulfoxide (DMSO) cryoprotectants presents challenges due to associated toxicities. This article highlights the importance of cryopreservation in cell therapy, examines the potential harms of DMSO, and discusses relevant studies that shed...
Introduction to the Cell Therapy Workflow
Allogeneic Workflow: In the allogeneic approach, immune cells are sourced from healthy donors or established cell banks rather than the patient themselves. These donor cells are carefully selected and expanded in large quantities under controlled laboratory conditions. The expanded cells are then modified or activated to enhance their therapeutic properties, such as targeting specific disease markers...
No Margins
Medium
Large
Large Alt
Full
Gray Overlay
Cryopreservation in Cell Therapy Workflows: Overcoming the Limitations of DMSO-Based Formulations
Cryopreservation is a crucial step in cell therapy workflows, ensuring the long-term viability and availability of therapeutic cells. However, the use of traditional dimethyl sulfoxide (DMSO) cryoprotectants presents challenges due to associated toxicities. This article highlights the importance of cryopreservation in cell therapy, examines the potential harms of DMSO, and discusses relevant studies that shed...
Introduction to the Cell Therapy Workflow
Allogeneic Workflow: In the allogeneic approach, immune cells are sourced from healthy donors or established cell banks rather than the patient themselves. These donor cells are carefully selected and expanded in large quantities under controlled laboratory conditions. The expanded cells are then modified or activated to enhance their therapeutic properties, such as targeting specific disease markers...
Grid
Society for Low Temperature Biology Meeting 2023
ISSCR 2024
Introduction to the Cell Therapy Workflow
List
Society for Low Temperature Biology Meeting 2023
ISSCR 2024
Introduction to the Cell Therapy Workflow
Society for Low Temperature Biology Meeting 2023
Society for Low Temperature Biology Meeting 2023
ISSCR 2024
Society for Low Temperature Biology Meeting 2023
